On September 9, 2021 Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, reported that Jennifer Buell, PhD, President and COO of Agenus, will participate in the following upcoming conferences (Press release, Agenus, SEP 9, 2021, View Source [SID1234587538]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference presentation will be available on-demand from Monday, September 13, 2021, starting at 7:00 a.m. ET.
Baird 2021 Global Healthcare Conference presentation on Wednesday, September 15, 2021 from 4:20 p.m. to 4:50 p.m. ET.
A webcast and replay for the Baird 2021 Global Healthcare Conference may be accessed on the company’s website at View Source